Biontech Claims It Will Know In Two Weeks Whether The Covid 19 Vaccine It Developed With Pfizer Is Effective Against The New B 1 1 529 Variant Strain That Is Quickly Spreading In Southern Africa
According to the Financial Times, BioNTech is testing the COVID-19 vaccine it created with Pfizer against the new version that appears to have evolved in southern Africa, and will know in two weeks whether it works against the variant. Scientists and health officials are keenly monitoring the B.1.1.529 variety, which has been found in South Africa, Botswana, Hong Kong, and Israel. The variety contains 32 mutations in the spike protein, which is the component of the virus that binds to human cells and is the target of existing vaccinations and antibody therapies....